
New Immunotherapy Treatment for Lung Cancer: Tecentriq – In-Depth Doctor’s Interview
Roy Herbst, MD, PhD, chief of medical oncology
Yale Cancer Center, New Haven, Conn.
Roy Herbst, MD, PhD, chief of medical oncology
Yale Cancer Center, New Haven, Conn.
Jonathan Wilker, PhD, chemist and materials engineer and professor in the department of chemistry and school of materials engineering
Purdue University, Indianapolis, Ind.
K. Luan Phan, MD, professor and chair of the department of psychiatry and behavioral health
The Ohio State University Wexner Medical Center, Columbus, Ohio
Charles Matouk, MD, chief of neurovascular surgery and associate professor
Yale University, New Haven, Conn.
William Fissell, MD, Associate Professor of Medicine, Division of Nephrology and Hypertension
Vanderbilt University Medical Center, NASHVILLE, Tenn.
Jason Gerrard, MD, PhD, Assistant Professor of Neurosurgery and Neuroscience
Yale School of Medicine, New Haven, Conn.
Timothy Burns, MD, PHD, Medical Oncologist specializing in Lung Cancer treatment
UPMC Hillman Cancer Center and the University of Pittsburgh Department of Medicine
Russell Butterfield, MD, PhD Pediatric Neurologist and Neuromuscular Specialist, Associate Professor of Neurology
University of Utah Health and Intermountain Primary Children’s Hospital
Xavier Simcock, MD, hand, and upper extremity surgeon
Midwest Orthopedics at Rush, Chicago, Ill.
Nikhil Verma, MD, Sports Medicine Surgeon, Director of the Division of Sports Medicine
Midwest Orthopaedics at Rush, Rush University Medical CenterSEATTLE, Wash.